-
1
-
-
84920837701
-
Cancer statistics, 2015
-
PID: 25559415
-
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
-
(2015)
CA Cancer J Clin
, vol.65
, Issue.1
, pp. 5-29
-
-
Siegel, R.L.1
Miller, K.D.2
Jemal, A.3
-
2
-
-
77953687835
-
Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach
-
PID: 20483517
-
Kim S, Dolecek TA, Davis FG. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach. Soc Sci Med. 2010;71(2):274–81.
-
(2010)
Soc Sci Med
, vol.71
, Issue.2
, pp. 274-281
-
-
Kim, S.1
Dolecek, T.A.2
Davis, F.G.3
-
3
-
-
0036178190
-
Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer
-
PID: 11801872
-
Narod SA, Boyd J. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr Opin Obstet Gynecol. 2002;14(1):19–26.
-
(2002)
Curr Opin Obstet Gynecol
, vol.14
, Issue.1
, pp. 19-26
-
-
Narod, S.A.1
Boyd, J.2
-
4
-
-
84975806705
-
Inherited Mutations in Women With Ovarian Carcinoma
-
Norquist, B.M., et al., : p. 1–9. Using next generation sequencing techniques the authors demonstrate that close to 20% of ovarian cancer is associated with a germline mutation in a cancer susceptibility gene. The majority of these are in BRCA1/2
-
Norquist, B.M., et al., Inherited Mutations in Women With Ovarian Carcinoma. JAMA Oncol, 2015: p. 1–9. Using next generation sequencing techniques the authors demonstrate that close to 20% of ovarian cancer is associated with a germline mutation in a cancer susceptibility gene. The majority of these are in BRCA1/2.
-
(2015)
JAMA Oncol
-
-
-
5
-
-
34248170114
-
Meta-analysis of BRCA1 and BRCA2 penetrance
-
PID: 17416853
-
Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329–33.
-
(2007)
J Clin Oncol
, vol.25
, Issue.11
, pp. 1329-1333
-
-
Chen, S.1
Parmigiani, G.2
-
6
-
-
77956193440
-
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
-
COI: 1:CAS:528:DC%2BC3cXhtFWjsbrF, PID: 20810374
-
Domchek SM et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967–75.
-
(2010)
JAMA
, vol.304
, Issue.9
, pp. 967-975
-
-
Domchek, S.M.1
-
7
-
-
84964696210
-
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
-
PID: 25494812
-
Marchetti C et al. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Womens Health. 2014;14:150.
-
(2014)
BMC Womens Health
, vol.14
, pp. 150
-
-
Marchetti, C.1
-
8
-
-
40749132232
-
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
-
COI: 1:CAS:528:DC%2BD1cXkt1ChsL8%3D, PID: 18196574
-
Metcalfe KA et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2008;122(9):2017–22.
-
(2008)
Int J Cancer
, vol.122
, Issue.9
, pp. 2017-2022
-
-
Metcalfe, K.A.1
-
9
-
-
79958036419
-
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
-
COI: 1:CAS:528:DC%2BC3MXntlyksLg%3D, PID: 21642681
-
Buys SS et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295–303.
-
(2011)
JAMA
, vol.305
, Issue.22
, pp. 2295-2303
-
-
Buys, S.S.1
-
10
-
-
0032514413
-
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group
-
COI: 1:CAS:528:DyaK1cXlslWgtLw%3D, PID: 9700175
-
Narod SA et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med. 1998;339(7):424–8.
-
(1998)
N Engl J Med
, vol.339
, Issue.7
, pp. 424-428
-
-
Narod, S.A.1
-
11
-
-
0037021659
-
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
-
COI: 1:CAS:528:DC%2BD38XptlOitLo%3D, PID: 12464649
-
Narod SA et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2002;94(23):1773–9.
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.23
, pp. 1773-1779
-
-
Narod, S.A.1
-
12
-
-
33846187651
-
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
-
COI: 1:CAS:528:DC%2BD2sXhs1yqurs%3D, PID: 17117391
-
Lee Y et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211(1):26–35.
-
(2007)
J Pathol
, vol.211
, Issue.1
, pp. 26-35
-
-
Lee, Y.1
-
13
-
-
77954110971
-
Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications
-
PID: 20567141
-
Carlson JW et al. Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol. 2010;29(4):310–4.
-
(2010)
Int J Gynecol Pathol
, vol.29
, Issue.4
, pp. 310-314
-
-
Carlson, J.W.1
-
14
-
-
10544220023
-
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
-
COI: 1:STN:280:DyaK2s%2FivF2qtg%3D%3D, PID: 8875917
-
Rubin SC et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 1996;335(19):1413–6.
-
(1996)
N Engl J Med
, vol.335
, Issue.19
, pp. 1413-1416
-
-
Rubin, S.C.1
-
15
-
-
57149093237
-
"BRCAness" syndrome in ovarian cancer: a case–control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations
-
PID: 18955455
-
Tan DS et al. "BRCAness" syndrome in ovarian cancer: a case–control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol. 2008;26(34):5530–6.
-
(2008)
J Clin Oncol
, vol.26
, Issue.34
, pp. 5530-5536
-
-
Tan, D.S.1
-
16
-
-
77955039099
-
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
-
COI: 1:CAS:528:DC%2BC3cXpt1Kktb4%3D, PID: 20609468
-
Audeh MW et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet. 2010;376(9737):245–51.
-
(2010)
Lancet
, vol.376
, Issue.9737
, pp. 245-251
-
-
Audeh, M.W.1
-
17
-
-
84953204390
-
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
-
COI: 1:CAS:528:DC%2BC2MXitV2rs7zP, PID: 26723501
-
Domchek SM et al. Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. Gynecol Oncol. 2016;140(2):199–203.
-
(2016)
Gynecol Oncol
, vol.140
, Issue.2
, pp. 199-203
-
-
Domchek, S.M.1
-
18
-
-
84894268890
-
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation
-
PID: 24366442
-
Nelson HD et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2014;160(4):255–66.
-
(2014)
Ann Intern Med
, vol.160
, Issue.4
, pp. 255-266
-
-
Nelson, H.D.1
-
19
-
-
84943787980
-
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance
-
Eccles, D.M., et al., BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol, 2015.
-
(2015)
Ann Oncol
-
-
Eccles, D.M.1
-
20
-
-
70349651005
-
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups
-
COI: 1:STN:280:DC%2BD1MnjvFOhtw%3D%3D, PID: 19491284
-
Haffty BG et al. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Ann Oncol. 2009;20(10):1653–9.
-
(2009)
Ann Oncol
, vol.20
, Issue.10
, pp. 1653-1659
-
-
Haffty, B.G.1
-
21
-
-
65649112508
-
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer
-
COI: 1:CAS:528:DC%2BD1MXlvFOhsrw%3D, PID: 19241424
-
Hall MJ et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115(10):2222–33.
-
(2009)
Cancer
, vol.115
, Issue.10
, pp. 2222-2233
-
-
Hall, M.J.1
-
22
-
-
84933574451
-
Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer
-
PID: 25847940
-
Jagsi R et al. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. J Clin Oncol. 2015;33(14):1584–91.
-
(2015)
J Clin Oncol
, vol.33
, Issue.14
, pp. 1584-1591
-
-
Jagsi, R.1
-
23
-
-
0037087536
-
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals
-
COI: 1:CAS:528:DC%2BD38XivFeisbY%3D, PID: 11896095
-
Frank TS et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20(6):1480–90.
-
(2002)
J Clin Oncol
, vol.20
, Issue.6
, pp. 1480-1490
-
-
Frank, T.S.1
-
24
-
-
0032565070
-
Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
-
COI: 1:CAS:528:DyaK1cXitlyju7Y%3D, PID: 9544765
-
Newman B et al. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA. 1998;279(12):915–21.
-
(1998)
JAMA
, vol.279
, Issue.12
, pp. 915-921
-
-
Newman, B.1
-
25
-
-
37549036689
-
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups
-
COI: 1:CAS:528:DC%2BD1cXmvFOr, PID: 18159056
-
John EM et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA. 2007;298(24):2869–76.
-
(2007)
JAMA
, vol.298
, Issue.24
, pp. 2869-2876
-
-
John, E.M.1
-
26
-
-
33748092354
-
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years
-
COI: 1:CAS:528:DC%2BD28XotFWqu74%3D, PID: 16912212
-
Malone KE et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res. 2006;66(16):8297–308.
-
(2006)
Cancer Res
, vol.66
, Issue.16
, pp. 8297-8308
-
-
Malone, K.E.1
-
27
-
-
84948582795
-
-
A high frequency of BRCA mutations in young black women with breast cancer residing in Florida, Cancer
-
Pal, T., et al., A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer, 2015.
-
(2015)
et al.
-
-
Pal, T.1
-
28
-
-
84939252201
-
Deleterious BRCA1/2 mutations in an urban population of Black women
-
COI: 1:CAS:528:DC%2BC2MXhtlelsbzK, PID: 26250392
-
Lynce F et al. Deleterious BRCA1/2 mutations in an urban population of Black women. Breast Cancer Res Treat. 2015;153(1):201–9.
-
(2015)
Breast Cancer Res Treat
, vol.153
, Issue.1
, pp. 201-209
-
-
Lynce, F.1
-
29
-
-
16444381731
-
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
-
COI: 1:CAS:528:DC%2BD2MXjtlWmtLc%3D, PID: 15827311
-
Armstrong K et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293(14):1729–36.
-
(2005)
JAMA
, vol.293
, Issue.14
, pp. 1729-1736
-
-
Armstrong, K.1
-
30
-
-
37849013468
-
Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer
-
PID: 18165638
-
Susswein LR et al. Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. J Clin Oncol. 2008;26(1):32–6.
-
(2008)
J Clin Oncol
, vol.26
, Issue.1
, pp. 32-36
-
-
Susswein, L.R.1
-
31
-
-
79955009383
-
Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk
-
PID: 21358336
-
Levy DE et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011;13(4):349–55.
-
(2011)
Genet Med
, vol.13
, Issue.4
, pp. 349-355
-
-
Levy, D.E.1
-
32
-
-
84921362893
-
American BRCA Outcomes and Utilization of Testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting
-
PID: 25209347
-
Armstrong J et al. American BRCA Outcomes and Utilization of Testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting. J Genet Couns. 2015;24(1):18–28.
-
(2015)
J Genet Couns
, vol.24
, Issue.1
, pp. 18-28
-
-
Armstrong, J.1
-
34
-
-
33645457117
-
Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups
-
PID: 16434605
-
Kaplan CP et al. Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev. 2006;15(1):162–6.
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, Issue.1
, pp. 162-166
-
-
Kaplan, C.P.1
-
35
-
-
84978473330
-
-
[cited 2014 December 20]; Available from
-
Pew Internet and American Life Project. 2014 [cited 2014 December 20]; Available from: http://www.pewinternet.org/fact-sheets/health-fact-sheet/.
-
(2014)
Pew Internet and American Life Project
-
-
-
36
-
-
84904008573
-
A randomized, controlled trial to increase discussion of breast cancer in primary care
-
Kaplan CP et al. A randomized, controlled trial to increase discussion of breast cancer in primary care. Cancer Epidemiol, Biomarkers Prev: Publ Am Assoc Cancer Res, Cosponsored Am Soc Prev Oncol. 2014;23(7):1245–53.
-
(2014)
Cancer Epidemiol, Biomarkers Prev: Publ Am Assoc Cancer Res, Cosponsored Am Soc Prev Oncol
, vol.23
, Issue.7
, pp. 1245-1253
-
-
Kaplan, C.P.1
-
37
-
-
68349121468
-
Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women’s Health Demonstration Project
-
Clark CR et al. Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women’s Health Demonstration Project. J Women’s Health. 2009;18(5):677–90.
-
(2009)
J Women’s Health
, vol.18
, Issue.5
, pp. 677-690
-
-
Clark, C.R.1
-
38
-
-
84921644693
-
Multiple barriers delay care among women with abnormal cancer screening despite patient navigation
-
Ramachandran A et al. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation. J Women’s Health. 2015;24(1):30–6.
-
(2015)
J Women’s Health
, vol.24
, Issue.1
, pp. 30-36
-
-
Ramachandran, A.1
-
39
-
-
84923083184
-
Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women
-
Percac-Lima S et al. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Women’s Health. 2015;24(2):138–43.
-
(2015)
J Women’s Health
, vol.24
, Issue.2
, pp. 138-143
-
-
Percac-Lima, S.1
-
41
-
-
78751580532
-
Patient navigation: the promise to reduce health disparities
-
PID: 21161422
-
Freund KM. Patient navigation: the promise to reduce health disparities. J Gen Intern Med. 2011;26(2):110–2.
-
(2011)
J Gen Intern Med
, vol.26
, Issue.2
, pp. 110-112
-
-
Freund, K.M.1
-
42
-
-
79960710009
-
Assessing the impact of patient navigation: prevention and early detection metrics
-
PID: 21780090
-
Battaglia TA et al. Assessing the impact of patient navigation: prevention and early detection metrics. Cancer. 2011;117(15 Suppl):3553–64.
-
(2011)
Cancer
, vol.117
, pp. 3553-3564
-
-
Battaglia, T.A.1
-
43
-
-
79960708066
-
History and principles of patient navigation
-
PID: 21780088
-
Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer. 2011;117(15 Suppl):3539–42.
-
(2011)
Cancer
, vol.117
, pp. 3539-3542
-
-
Freeman, H.P.1
Rodriguez, R.L.2
-
44
-
-
84909641270
-
Bridging the gap: a community health program saved lives, then closed its doors
-
Behforouz HL. Bridging the gap: a community health program saved lives, then closed its doors. Health Aff. 2014;33(11):2064–7.
-
(2014)
Health Aff
, vol.33
, Issue.11
, pp. 2064-2067
-
-
Behforouz, H.L.1
|